Immunophenotypic Features of Myeloid Neoplasms Associated with Chromosome 7 Abnormalities

Cytometry. Part B, Clinical Cytometry
Xueyan ChenSindhu Cherian

Abstract

Abnormalities involving chromosome 7 are one of the most frequent chromosomal aberrations in myeloid neoplasms including myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and are associated with an adverse prognosis. Immunophenotyping by flow cytometry provides data that can assist in the diagnosis and classification of myeloid neoplasms. The immunophenotypic features of myeloid neoplasms with monosomy 7 or del(7q) have not been previously described in a comprehensive fashion. We retrospectively analyzed flow cytometric data of myeloid neoplasms with monosomy 7 or del(7q) and summarized associated immunophenotypic features. Myeloid neoplasms with monosomy 7 typically demonstrate multiple immunophenotypic abnormalities on myeloid blasts and maturing myelomonocytic cells. Increased CD14 expression on maturing granulocytic cells was characteristically seen in myeloid neoplasms with monosomy 7. This abnormality was significantly more frequent in myeloid neoplasms with monosomy 7 than in those with del(7q) (92.9% vs. 8.2%, P < 0.0001). The presence of increased CD14 expression on maturing granulocytic cells could be seen in cases with monosomy 7 in the setting of a normal blast percentage and when minimal (<3) other i...Continue Reading

References

May 7, 1992·The New England Journal of Medicine·S KojimaT Matsuyama
Dec 25, 2003·Leukemia & Lymphoma·Haytham KhouryStephen H Nantel
Jun 8, 2004·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Haytham KhouryThomas J Nevill
Dec 18, 2004·Methods in Cell Biology·Brent Wood
Jan 26, 2005·Cytometry. Part B, Clinical Cytometry·Sindhu CherianAdam Bagg
Sep 19, 2007·American Journal of Clinical Pathology·Jitakshi DeBruce H Davis
Jul 1, 2011·Cancer·Iris CordobaUNKNOWN Spanish Myelodysplastic Syndrome Registry
Feb 15, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Julie SchanzDetlef Haase
Sep 19, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Krzysztof MrózekClara D Bloomfield
May 15, 2013·Methods in Molecular Biology·Brent L Wood
Nov 13, 2013·The Journal of Experimental Medicine·Tomoya MutoAtsushi Iwama
May 10, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Daniela F AngeliniFrancesco Lo-Coco
Jan 26, 2017·Leukemia Research·Hatice Deniz GurGuilin Tang

❮ Previous
Next ❯

Related Concepts

Related Feeds

AML: Role of LSD1 by CRISPR (Keystone)

Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.